B. Bereznai

发表

A susceptibility locus for Parkinson's disease maps to chromosome 2p13

B. Müller-Myhsok, Z. Wszolek, P. Vieregge, 1998, Nature Genetics.

The rs13388259 Intergenic Polymorphism in the Genomic Context of the BCYRN1 Gene Is Associated with Parkinson's Disease in the Hungarian Population

P. Klivényi, L. Vécsei, A. Takáts, 2018, Parkinson's disease.

The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease.

C. Marsden, Y. Agid, A. Durr, 1998, Annals of neurology.

Guillain‐Barré syndrome during SARS‐CoV‐2 pandemic: A case report and review of recent literature

B. Bereznai, E. Scheidl, Daniel Diez Canseco, 2020, Journal of the peripheral nervous system : JPNS.

Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson’s disease

C. Gieger, A. Peters, B. Mollenhauer, 2012, neurogenetics.

Genetic complexity and Parkinson's disease.

Y. Agid, B. Müller-Myhsok, A. Dürr, 1997, Science.

A novel SOD1 mutation in an Austrian family with amyotrophic lateral sclerosis

T. Gasser, G. Borasio, B. Bereznai, 1997, Neuromuscular Disorders.

Coexisting huntingtin and SCA8 repeat expansion: Case report of a severe complex neurodegenerative syndrome

G. Rudas, M. Molnár, G. Lovas, 2010, Journal of the Neurological Sciences.

Three novel mutations and genetic epidemiology analysis of the Gap Junction Beta 1 (GJB1) gene among Hungarian Charcot-Marie-Tooth disease patients

E. Varga, M. Molnár, P. Diószeghy, 2016, Neuromuscular Disorders.

[Clinical manifestations, course and outcome of enzyme replacement therapy in Hungarian patients with Pompe's disease].

I. György, Z. Illés, Z. Almássy, 2011, Orvosi hetilap.

MELAS syndrome mimicking somatoform disorder

Á. Mészáros, G. Blaskó, M. Molnár, 2011 .

MELAS syndrome mimicking somatoform disorder – a case report

Blasko, Á. Mészáros, M. Molnár, 2011 .

[Therapy for anti-MuSK antibody positive myasthenia gravis].

Z. Pál, M. Molnár, G. Lovas, 2011, Orvosi hetilap.

The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease

Nicholas W. Wood, Matthew J. Farrer, Vincenzo Bonifati, 1999, Neuroscience Letters.

The role of SCARB2 as susceptibility factor in Parkinson's disease

C. Gieger, A. Peters, B. Mollenhauer, 2013, Movement disorders : official journal of the Movement Disorder Society.

(3H)dipyridamole and (3H)nitrobenzylthioinosine binding sites at the human parietal cortex and erythrocyte adenosine transporter: a comparison.

P. Riederer, J. Deckert, J. Fritze, 1994, Life sciences.

Nimodipine inhibits [3H]nitrobenzylthioinosine binding to the adenosine transporter in human brain.

P. Riederer, J. Deckert, J. Fritze, 1993, European journal of pharmacology.

Rare variants in β-Amyloid precursor protein (APP) and Parkinson’s disease

Christian Gieger, Dietrich Haubenberger, Thomas Meitinger, 2015, European Journal of Human Genetics.

Rare Variants in PLXNA4 and Parkinson’s Disease

C. Gieger, A. Peters, B. Mollenhauer, 2013, PloS one.

The α‐synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases

C. Marsden, Y. Agid, A. Durr, 1998 .

Different patterns of nerve enlargement in polyneuropathy subtypes as detected by ultrasonography.

D. Bereczki, M. Simó, B. Bereznai, 2014, Ultrasound in medicine & biology.

The modifying effect a PMP22 deletion in a family with Charcot-Marie-Tooth type 1 neuropathy due to an EGR2 mutation.

F. Mechler, Z. Pál, M. Molnár, 2014, Ideggyogyaszati szemle.

Mitochondrial DNA mutations and cognition: a case-series report.

J. Trampush, Z. Varga, M. Molnár, 2014, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Linkage studies in alcohol‐responsive myoclonic dystonia

G. Deuschl, W. Oertel, T. Gasser, 1996, Movement disorders : official journal of the Movement Disorder Society.

Ultrasonography of MADSAM neuropathy: Focal nerve enlargements at sites of existing and resolved conduction blocks

T. Kovács, M. Simó, B. Bereznai, 2012, Neuromuscular Disorders.

Psychiatric symptoms of patients with primary mitochondrial DNA disorders

Petra Balla, Z. Varga, M. Molnár, 2012, Behavioral and Brain Functions.

Phenotypic expression of the DYT1 mutation: A family with writer's cramp of juvenile onset

T Gasser, T. Gasser, A. Ludolph, 1998, Annals of neurology.

Chronic high‐frequency globus pallidus internus stimulation in different types of dystonia: A clinical, video, and MRI report of six patients presenting with segmental, cervical, and generalized dystonia

K. Bötzel, U. Steude, K. Seelos, 2002, Movement disorders : official journal of the Movement Disorder Society.

Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson’s disease

C. Gieger, A. Peters, B. Mollenhauer, 2012, neurogenetics.

Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson′s disease

Thomas Gasser, Erwin Ott, F. Asmus, 2003, Neurogenetics.

MELAS syndrome mimicking somatoform disorder Central European

Á. Mészáros, G. Blaskó, M. Molnár, 2011 .

The coexistence of dynamin 2 mutation and multiple mitochondrial DNA (mtDNA) deletions in the background of severe cardiomyopathy and centronuclear myopathy.

B. Merkely, Z. Szelid, M. Molnár, 2015, Clinical neuropathology.

Mitochondrial DNA mutations and cognition: a case-series report.

J. Trampush, Z. Varga, M. Molnár, 2014, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.